Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia

American Journal of Obstetrics and Gynecology

Volumn 183, Issue 6, 2000, Pages 1554-1557

  Livingston, Jeffrey C ^a,b   Chin, Robert ^a,b   Haddad, Bassam ^a,b   McKinney, Elizabeth T ^a,b   Ahokas, Robert ^a,b   Sibai, Baha M ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Placental growth factor; Preeclampsia; Pregnancy; Vascular endothelial growth factor

Indexed keywords

GROWTH FACTOR; PLACENTAL GROWTH FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS;

EID: 0034524141     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2000.108022     Document Type: Article

References (14)

1. Hypertension in pregnancy
2. Maternal plasma concentrations of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by preeclampsia
3. Elevated plasma concentrations of vascular endothelial growth factor in patients with preeclampsia
4. Vascular endothelial growth factor is increased in patients with preeclampsia
5. Suppression of plasma vascular endothelial growth factor immunoreactivity in normal pregnancy and in preeclampsia
6. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor
7. A heparin-binding form of placental growth factor (PLGF-2) is expressed in human vein endothelial cells and in the placenta
8. Preeclampsia is associated with reduced serum levels of placenta growth factor
9. Selective deficit of angiogenic growth factors characterized pregnancies complicated by pre-eclampsia
10. Purification and characterization of a naturally occurring vascular endothelial growth factor-placenta growth factor heterodimer
11. Regulation of human placental development by oxygen tension
12. Expression of vascular endothelial growth factor and placental growth factor in human placenta
13. Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins
14. Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26 to 42 weeks